Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sufentanil disposition. Is it affected by erythromycin administration?

R R Bartkowski1, M E Goldberg, S Huffnagle

  • 1Department of Anesthesiology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-5092.

Anesthesiology
|February 1, 1993
PubMed
Summary

Erythromycin does not affect how the body processes sufentanil, a potent opioid analgesic. This study found no significant changes in sufentanil pharmacokinetics after erythromycin administration, ensuring patient safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distributed Population Coding and Memory Consolidation in the Cerebellar Cortex and Dentate Nucleus.

bioRxiv : the preprint server for biology·2025
Same author

Literature search for healthcare management decision-making on how to increase productivity by performing more surgical cases in the same staffed time.

Revista espanola de anestesiologia y reanimacion..·2024
Same author

Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in Pennsylvania.

Substance abuse·2022
Same author

Implications of variation by time of day in post-anaesthesia care unit length of stay for rational nurse staffing.

British journal of anaesthesia·2018
Same author

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Hypotension during induction of anaesthesia is neither a reliable nor a useful quality measure for comparison of anaesthetists' performance.

British journal of anaesthesia·2017

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Drug Metabolism

Background:

  • Oral erythromycin can reduce the elimination of alfentanil.
  • This raises concerns about potential interactions with related opioids like sufentanil.
  • Sufentanil shares metabolic pathways with alfentanil, necessitating pharmacokinetic investigation.

Purpose of the Study:

  • To investigate the pharmacokinetic interaction between erythromycin and sufentanil.
  • To determine if erythromycin alters sufentanil's absorption, distribution, metabolism, or excretion.
  • To assess the clinical implications of co-administering erythromycin and sufentanil.

Main Methods:

  • A controlled crossover study involving six healthy subjects.
  • Intravenous administration of sufentanil (3 micrograms/kg) was performed.

Related Experiment Videos

  • Plasma concentrations were measured for 9 hours post-administration, with and without prior erythromycin treatment (1- and 7-day courses).

    • Main Results:

    • Plasma concentrations of sufentanil remained consistent before and after erythromycin administration.
    • No significant changes were observed in terminal half-life, clearance, or volume of distribution.
    • Pharmacokinetic parameters after a 7-day erythromycin course were comparable to control values.

    Conclusions:

    • Erythromycin administration does not alter the pharmacokinetics of sufentanil within 9 hours post-administration.
    • There are no apparent clinical consequences of using erythromycin before or concurrently with sufentanil for procedures up to 9 hours.
    • This suggests a lack of significant drug-drug interaction impacting sufentanil's clinical use in short-term procedures.